Sanofi at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Sanofi brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on finding and screening new AAV capsids. Topics include mining petabytes of metagenomic data for AAV sequences and a custom single-cell sequencing method that screens capsids in organoids using droplet microfluidics.

OrganizationESGCT 2026 Attendance
Sanofi
Paris, France
Large pharma
Global pharmaceutical company with programmes in rare diseases and genomic medicine.
Talk
Wed Oct 28
9:30am–10:30am
MADCAP: Unearthing Metagenomic AAV Caches with Deep Petascale Mining
SESSION 3a: AAVs/non integrative vectors II - Technology
Vectors and delivery (AAV, lentiviral, LNP)
Poster
Thu Oct 29
2:00pm–4:00pm
Custom single cell RNA sequencing approach for adeno-associated virus screening to advance gene therapy using organoids and droplet microfluidics
AAVs / non integrative vectors

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Sanofi

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction